Single-use Bioprocessing Probes And Sensors Market (2026 - 2033)

Single-use Bioprocessing Probes & Sensors Market Summary

The global single-use bioprocessing probes & sensors market size was valued at USD 3.7 billion in 2025 and is projected to grow from USD 4.1 billion in 2026 to USD 8.8 billion in 2033, at a CAGR of 11.6% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of approximately 40.0% in 2025. The increasing implementation of single-use technology (SUT) in bioproduction, the commercial advantages over conventional products, and the rising demand for improved bioprocess monitoring are among the factors driving market growth.

Regional Insights

• Largest regional market: North America (Approximately 40.0% revenue share, 2025)
• Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)

The implementation of SUT in bio-manufacturing processes offers several advantages that resonate throughout the biopharmaceutical industry. Single-use systems significantly reduce the risk of cross-contamination, ensuring product purity and integrity. By eliminating the need for cleaning and sterilization between batches, these systems enhance operational efficiency, leading to shorter turnaround times and increased productivity. Moreover, single-use technology offers greater flexibility in scaling production, allowing manufacturers to adapt quickly to changing market demand. This agility is particularly valuable in upstream bioprocessing, where the ability to rapidly adjust production volumes can optimize resource utilization and minimize costs. As biomanufacturers attempt to rationalize the processes and accelerate the growth of bioprocessing, the advantages associated with single-use products, such as sensors and probes, position them as a foundation of modern bioprocessing strategies, driving innovation and efficiency across the industry.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Furthermore, the commercial advantages of single-use sensors include streamlining operations, reducing costs, enhancing flexibility, and improving regulatory compliance & product quality. These benefits make them an attractive option for companies aiming to optimize their processes and stay competitive in their respective fields. Reduced cleaning and sterilization costs, low capital expenditure, reduced risk of product cross-contamination, Increased process flexibility, etc., are some of the benefits offered by single-use sensors and probes over stainless steel. 

Moreover, the use of disposable sensors in single-use bioreactors provides a noninvasive measurement of critical parameters. The additional advantage of single-use sensors is that they do not require electrolytes, thereby reducing the equilibration time. Hence, disposable sensors & probes have gained widespread acceptance by offering various commercial advantages over conventional products. These advantages are major drivers of the single-use probes and sensors market.

Analyst Perspective

The market is witnessing robust growth, driven by the increasing demand for higher bioprocess efficiency, improved product quality, and stringent regulatory compliance in biopharmaceutical manufacturing. Biopharmaceutical manufacturers are increasingly integrating single-use probes and sensors into bioreactors, mixing systems, purification processes, and fluid management applications to enhance process monitoring, maintain sterility, minimize cross-contamination risks, and reduce turnaround times between production batches. The growing adoption of cell and gene therapies, personalized medicine, continuous bioprocessing, and advanced biologics manufacturing is further accelerating market expansion. As the industry increasingly prioritizes real-time process analytical technologies (PAT), automation, and data-driven manufacturing, companies focused on developing highly accurate, reliable, and scalable single-use sensing solutions are expected to capitalize on significant long-term growth opportunities.

Type Insights

The pH sensors segment accounted for the largest market share of over 20.0% in 2025. The segment's growth is driven by the increasing production of biopharmaceuticals, including monoclonal antibodies, vaccines, and cell and gene therapies, all of which require precise and continuous pH monitoring to ensure product quality, process consistency, and regulatory compliance. pH sensors are extensively used throughout bioprocessing workflows, from inoculation and cell culture in bioreactors to downstream harvesting and purification. Single-use pH sensors offer several advantages, including reduced risk of cross-contamination, elimination of cleaning and sterilization requirements, lower operating costs, and seamless integration into disposable bioprocessing systems. For instance, METTLER TOLEDO's single-use pH sensors are designed for integration into disposable bioreactors and process vessels, delivering accurate, reliable pH measurements to help optimize the production of monoclonal antibodies, vaccines, and cell and gene therapy products. Furthermore, the growing adoption of flexible manufacturing, personalized medicine, and small-batch biologics production continues to drive demand for single-use pH-sensing technologies.

Furthermore, the oxygen sensors segment is expected to grow at a significant CAGR over the forecast period. In biomanufacturing, oxygen and carbon dioxide are the most important gases to monitor. Changes in oxygen concentration may hamper metabolism, cell growth, and productivity. Optical oxygen sensors are the standard equipment for single-use bioreactors, as they enable noninvasive chemosensory operation.

Workflow Insights

The upstream segment dominated the market by revenue in 2025, with a market share of around 75.0%. In upstream bioprocessing, single-use sensors are used in media preparation, cell culture, and cell separation to measure pH, pressure, conductivity, temperature, turbidity, and flow. The sensors utilized in upstream bioprocessing can be categorized as either online or offline. Online sensors are further divided into in-line and at-line sensors. These sensors offer advantages such as minimizing the risk of cross-contamination and providing precise parameter monitoring, thereby enhancing productivity.

The downstream segment is anticipated to register strong growth over the forecast period. Downstream processing involves the separation, isolation, and purification of the final product from the cell culture. The harvested yield from upstream undergoes multiple unit operations to remove impurities and isolate the desired product. The most common in-line single-use sensors in downstream bioprocessing monitor pH, pressure, conductivity, temperature, turbidity, and flow. The gap in the market for downstream-specific single-use sensors presents an opportunity for manufacturers to innovate and develop products tailored to these processes. As the market moves toward more integrated and continuous processing, the demand for single-use sensors in downstream applications is expected to grow during the forecast period.

End-use Insights

The biopharmaceutical & pharmaceutical companies segment held the largest market share of over 40.0% in 2025. Pharmaceutical & biopharmaceutical companies are witnessing an increasing shift toward biologics and personalized medicine. Moreover, the commercial advantages of single-use sensors, such as cost-effectiveness, reduced labor costs, and others, are expected to increase their use in the biopharmaceuticals market soon.

The CROs & CMOs segment is expected to experience the fastest growth over the forecast period for several reasons. One of the primary drivers is increased outsourcing in drug development and manufacturing. Biopharmaceutical companies often collaborate with CMOs & CROs to leverage specialized expertise and reduce in-house costs. Furthermore, various CMOs are adding single-use bioreactor systems to scale up commercial manufacturing capacity, leading to an increasing number of CMOs becoming commercial product manufacturers. This rising number is also expected to drive the adoption of single-use sensors by CMOs and CROs.

Regional Insights

North America dominated the market, accounting for approximately 40.0% of the market share in 2025. This can be attributed to the increasing adoption of new technologies, such as single-use technology, coupled with the presence of major biopharmaceutical and biotechnology companies. In addition, the expanding applications of disposables in biomanufacturing plants by various companies, including in-house and CMOs, in the region are significantly contributing to the market growth.

To learn more about this report, Download Free Sample Report

U.S. Single-use Bioprocessing Probes & Sensors Market Trends

The single-use bioprocessing probes & sensors market in the U.S. is expected to grow significantly over the forecast period. The expansion of biopharmaceutical manufacturing facilities in the U.S. is propelling the adoption of single-use/disposable products in the production workflow. The increasing demand for single-use products in the bioprocessing industry has prompted many companies to pursue strategic initiatives. Moreover, the presence of key market players, such as Thermo Fisher Scientific, PendoTECH LLC, Hamilton Company, Polestar Technologies, Inc., Mettler Toledo LLC, and Broadley-James Corporation, is anticipated to drive the market in the country.

Asia Pacific Single-use Bioprocessing Probes & Sensors Market Trends

The single-use bioprocessing probes & sensors market in the Asia Pacific is anticipated to witness the fastest CAGR from 2026 to 2033. This can be attributed to biotechnology's broad reach and the region's rapid technological innovation. Furthermore, the growing biopharmaceutical and biotechnology sector in the region is anticipated to accelerate the adoption of single-use technologies, leading to an increase in the demand for single-use bioprocessing probes and sensors in the region.

China single-use bioprocessing probes & sensors marketis expected to register strong growth over the forecast period, driven by the rapid expansion of the country's biopharmaceutical industry and increasing investments in biologics, cell and gene therapies, and mRNA manufacturing. The growing presence of both domestic and international biopharmaceutical companies, coupled with strategic collaborations and capacity expansion initiatives, is accelerating the adoption of advanced single-use bioprocessing technologies. For instance, in November 2024, VectorBuilder, a global provider of gene delivery technologies, announced a cooperation agreement with Sartorius to advance gene vector and mRNA bioprocess solutions and services. The collaboration aims to accelerate the development and clinical translation of innovative biopharmaceutical therapies while supporting the adoption of advanced single-use manufacturing technologies, including process monitoring and analytical solutions.

The single-use bioprocessing probes & sensors market in Japanis anticipated to grow at a steady CAGR over the forecast period. Japan’s biopharmaceutical industry has witnessed a transformation due to an increase in the demand for biosimilars and biologics, which is anticipated to positively impact the bioprocessing market in the country. This is expected to contribute to the increasing adoption of single-use sensors in the country in the coming years.

India single-use bioprocessing probes & sensors market is anticipated to grow at a healthy rate over the forecast period. Currently, biopharmaceuticals are the fastest-growing segment in the Indian pharmaceutical industry. The expanding biopharmaceutical industry in the country is anticipated to increase the adoption of single-use sensors in the production workflow.

Europe Single-use Bioprocessing Probes & Sensors Market Trends

The single-use bioprocessing probes & sensors market in Europe accounted for a significant share of the global market in 2025. The region's growth is driven by strong government support and strategic investments by private organizations to advance biopharmaceutical manufacturing and expand bioprocessing capabilities. Increasing adoption of upstream single-use bioprocessing equipment, coupled with the growing emphasis on process efficiency, contamination control, and regulatory compliance, is expected to support sustained market growth throughout the forecast period.

The UK single-use bioprocessing probes & sensors marketis expected to grow steadily over the forecast period. To meet the changing market demands, the biopharmaceutical industry in the UK is embracing single-use technologies for the manufacturing of biopharmaceutical products.

The single-use bioprocessing probes & sensors market in Germanyis expected to witness steady growth over the forecast period. The country is home to several leading bioprocessing technology providers and life sciences companies, fostering continuous innovation and facilitating access to advanced upstream bioprocessing equipment. Strong investments in biologics manufacturing, research infrastructure, and process development, coupled with the increasing adoption of single-use technologies, are expected to drive market growth and reinforce Germany's position as one of the leading markets for single-use bioprocessing probes & sensors in Europe.

France single-use bioprocessing probes & sensors market is expected to be driven by the expanding presence of biopharmaceutical companies and favorable government initiatives supporting biotechnology research, biomanufacturing, and life sciences innovation. In addition, increasing investments by global biopharmaceutical companies in France’s biopharmaceutical industry and growing collaborations with local CROs & CMOs are expected to drive the market for single-use probes and sensors in France.

Middle East & Africa Single-use Bioprocessing Probes & Sensors Market

The single-use bioprocessing probes & sensors market in MEA is expected to grow steadily over the forecast period, driven by increasing investment in the biopharmaceutical and biotechnology sectors across the region. Government initiatives to strengthen local biomanufacturing capabilities, coupled with rising foreign direct investments and the expansion of global biopharmaceutical companies, are accelerating the adoption of single-use bioprocessing technologies. The growing focus on establishing regional manufacturing capabilities for biologics and vaccines is further expected to support market growth.

The UAE single-use bioprocessing probes & sensors marketis expected to expand over the forecast period, supported by the country's strategic efforts to establish a competitive biotechnology and pharmaceutical industry as part of its economic diversification agenda. Rising investments in life sciences, increasing adoption of advanced biomanufacturing technologies, and the expansion of research and pharmaceutical manufacturing facilities are expected to drive demand for single-use bioprocessing probes and sensors across the country.

Key Single-use Bioprocessing Probes & Sensors Company Insights

Key players in the market are undertaking initiatives to strengthen their market presence and expand the reach of their products and services. Strategies such as expansion activities and partnerships play a key role in propelling market growth.

Key Single-use Bioprocessing Probes & Sensors Companies

The following key companies have been profiled for this study in the single-use bioprocessing probes & sensors market:

• Hamilton Company

• Thermo Fisher Scientific Inc.

• Parker-Hannifin Corporation

• Danaher Corporation

• Mettler-Toledo International Inc. (PendoTECH)

• PreSens Precision Sensing GmbH

• Sartorius AG

• Broadley-James Corporation

• Saint-Gobain (Equflow)

• Dover Corporation

Recent Developments

• In June 2024, Qosina, a global supplier of OEM single-use components for the medical and pharmaceutical industries, announced a partnership with Polestar Technologies to expand its portfolio of single-use bioprocessing solutions. Through the collaboration, Qosina added Polestar's iDOT™ Single-Use Sensor Bag Ports, which provide pre-calibrated, gamma-stable, non-invasive optical sensing for real-time process monitoring in disposable bioprocessing systems.

• In April 2025, Sartorius Stedim Biotech announced a strategic partnership with Tulip Interfaces to accelerate digital transformation in biopharmaceutical manufacturing. The collaboration combines Sartorius' bioprocessing technologies with Tulip's frontline operations platform to deliver Biobrain Operate powered by Tulip, a digital manufacturing solution that integrates seamlessly with bioprocess equipment, improving process monitoring, operational efficiency, and data-driven manufacturing.

Global Single-use Bioprocessing Probes & Sensors Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global single-use bioprocessing probes & sensors market report based on type, workflow, end-use, and region:

• Type Outlook (Revenue, USD Billion, 2021 - 2033)

  • pH Sensor

  • Oxygen Sensors

  • Pressure Sensors

  • Temperature Sensors

  • Conductivity Sensors

  • Flow Meter & Sensors

  • Other Sensors

• Workflow Outlook (Revenue, USD Billion, 2021 - 2033)

  • Upstream

    • pH Sensor

    • Oxygen Sensors

    • Pressure Sensors

    • Temperature Sensors

    • Conductivity Sensors

    • Flow Meter & Sensors

    • Other Sensors

  • Downstream

    • pH Sensor

    • Pressure Sensors

    • Temperature Sensors

    • Conductivity Sensors

    • Flow Meter & Sensors

    • Other Sensors

• End-use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Biopharmaceutical & Pharmaceutical Companies

  • CROs & CMOs

  • Academic & Research Institutes

  • Other End Uses

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • EuropeAsia Pacific

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin AmericaMEA

    • Brazil

    • Argentina

  • • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait